The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility

The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1–KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator IC...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pharmacology and experimental therapeutics Vol. 354; no. 3; pp. 290 - 301
Main Authors Provence, Aaron, Malysz, John, Petkov, Georgi V.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.09.2015
The American Society for Pharmacology and Experimental Therapeutics
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1–KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca2+ imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K+ (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca2+ concentration in DSM cells, an effect blocked by the L-type Ca2+ channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels.
AbstractList The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1–KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca2+ imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K+ (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca2+ concentration in DSM cells, an effect blocked by the L-type Ca2+ channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels.
The physiologic roles of voltage-gated K V 7 channel subtypes (K V 7.1–K V 7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of K V 7.2/K V 7.3 channels in guinea pig DSM excitability and contractility using the novel K V 7.2/K V 7.3 channel activator ICA-069673 [ N -(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca 2+ imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of K V 7.2 and K V 7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for K V 7.2 and K V 7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the K V 7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10 H )-anthracenone dihydrochloride]. Under conditions of elevated extracellular K + (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca 2+ concentration in DSM cells, an effect blocked by the L-type Ca 2+ channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel K V 7.2/K V 7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the K V 7.2- and K V 7.3-containing channels in DSM function at both cellular and tissue levels.
The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca(2+) imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K(+) (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels.The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca(2+) imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K(+) (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels.
The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate the functional roles of KV7.2/KV7.3 channels in guinea pig DSM excitability and contractility using the novel KV7.2/KV7.3 channel activator ICA-069673 [N-(2-chloro-5-pyrimidinyl)-3,4-difluorobenzamide]. We employed a multilevel experimental approach using Western blot analysis, immunocytochemistry, isometric DSM tension recordings, fluorescence Ca(2+) imaging, and perforated whole-cell patch-clamp electrophysiology. Western blot experiments revealed the protein expression of KV7.2 and KV7.3 channel subunits in DSM tissue. In isolated DSM cells, immunocytochemistry with confocal microscopy further confirmed protein expression for KV7.2 and KV7.3 channel subunits, where they localize within the vicinity of the cell membrane. ICA-069673 inhibited spontaneous phasic, pharmacologically induced, and nerve-evoked contractions in DSM isolated strips in a concentration-dependent manner. The inhibitory effects of ICA-069673 on DSM spontaneous phasic and tonic contractions were abolished in the presence of the KV7 channel inhibitor XE991 [10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone dihydrochloride]. Under conditions of elevated extracellular K(+) (60 mM), the effects of ICA-069673 on DSM tonic contractions were significantly attenuated. ICA-069673 decreased the global intracellular Ca(2+) concentration in DSM cells, an effect blocked by the L-type Ca(2+) channel inhibitor nifedipine. ICA-069673 hyperpolarized the membrane potential and inhibited spontaneous action potentials of isolated DSM cells, effects that were blocked in the presence of XE991. In conclusion, using the novel KV7.2/KV7.3 channel activator ICA-069673, this study provides strong evidence for a critical role for the KV7.2- and KV7.3-containing channels in DSM function at both cellular and tissue levels.
Author Provence, Aaron
Malysz, John
Petkov, Georgi V.
Author_xml – sequence: 1
  givenname: Aaron
  surname: Provence
  fullname: Provence, Aaron
– sequence: 2
  givenname: John
  surname: Malysz
  fullname: Malysz, John
– sequence: 3
  givenname: Georgi V.
  surname: Petkov
  fullname: Petkov, Georgi V.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26087697$$D View this record in MEDLINE/PubMed
BookMark eNp9UcFu1DAQtVAR3bacuSEfuWTXsWMnuSChpS2I0qJuy9VynHHXVdZO7WTFfgz_iqMtFVSCiz2aee_N6L0jdOC8A4Te5GSe57RY3PcwpIrPKeVUVC_QLOc0z0hO2AGaEUJpxrjgh-goxntC8qIQ7BU6pIJUpajLGfp5swZ86bfQ4S_fyzldTC_Dy7VyLvWuenAQ8Oflh4yIWpQMX8MWVBfxamyGXQ_ZqgdtjdX4bHR6sN6pDl_7DiK2Dp-P1oHC3-wd_ghDGKMPeLXxfljjr2PUHeDTH9oOqrGdHXZYuRYvvRuCSkpT5wS9NGkZvH78j9Ht2enN8lN2cXWebrrINONVlRlWsxo4NIy0pDYNawRRCjjnhWGmMoLWbZqVLDlFNC_a1rQGqE6msbYuGDtG7_e6_dhsoNUw3dDJPtiNCjvplZV_T5xdyzu_lQVnVVVOAu8eBYJ_GCEOcmOjhq5TDvwYZS7qqhZF8jBB3_6562nJ70wSYLEH6OBjDGCeIDmRU-pySj1VXO5TTwz-jDGZOoWRjrXdf3j1ngfJ262FIKO24DS0NoAeZOvtP7m_AKdfxZ8
CitedBy_id crossref_primary_10_1113_JP277021
crossref_primary_10_1124_jpet_117_243162
crossref_primary_10_1016_j_pharmthera_2016_05_002
crossref_primary_10_3389_fphys_2020_01004
crossref_primary_10_1113_JP284744
crossref_primary_10_1080_17460441_2024_2438226
crossref_primary_10_1152_ajpcell_00055_2019
crossref_primary_10_1002_nau_24228
crossref_primary_10_1039_D0MD00328J
crossref_primary_10_1038_s41380_023_02218_5
crossref_primary_10_3389_fphar_2023_1138556
crossref_primary_10_14814_phy2_14754
crossref_primary_10_1111_bcpt_13881
crossref_primary_10_1152_ajprenal_00048_2020
Cites_doi 10.1152/physrev.00038.2003
10.1111/bph.12805
10.1111/j.1528-1167.2012.03441.x
10.1016/j.tips.2007.11.010
10.1021/ml200053x
10.1124/mol.114.093799
10.1097/FJC.0b013e3182771708
10.1152/ajpregu.00142.2014
10.1124/pr.56.4.4
10.1152/ajplung.00194.2011
10.1016/j.drudis.2013.12.003
10.1124/mol.107.043216
10.1111/j.1476-5381.2010.01027.x
10.1124/jpet.108.137794
10.1371/journal.pone.0117350
10.1152/ajpgi.00057.2009
10.1161/CIRCULATIONAHA.111.032136
10.1111/j.1476-5381.2009.00131.x
10.1371/journal.pone.0075875
10.3389/fphar.2012.00142
10.1152/ajpcell.00447.2011
10.1097/01.ju.0000138155.33749.f4
10.1016/j.ejphar.2013.05.005
10.1038/nrurol.2011.194
10.1111/bph.12210
10.1073/pnas.0911294107
10.1111/j.1742-7843.2011.00765.x
10.1111/j.1528-1167.2011.03365.x
10.1016/j.ejphar.2010.03.050
10.1016/S0163-7258(01)00116-4
10.1152/ajpregu.00036.2010
10.1152/ajplung.00253.2013
10.1161/ATVBAHA.114.303405
10.1152/ajpcell.00169.2012
10.1152/ajpcell.00303.2010
ContentType Journal Article
Copyright 2015 American Society for Pharmacology and Experimental Therapeutics
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics 2015
Copyright_xml – notice: 2015 American Society for Pharmacology and Experimental Therapeutics
– notice: Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.
– notice: Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1124/jpet.115.225268
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
DocumentTitleAlternate KV7.2/KV7.3 Channels and Bladder Function
EISSN 1521-0103
EndPage 301
ExternalDocumentID PMC4538873
26087697
10_1124_jpet_115_225268
S0022356524191057
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: R01-DK084284
– fundername: NIDDK NIH HHS
  grantid: R01 DK084284
– fundername: NIDDK NIH HHS
  grantid: F31-DK104528
– fundername: NIDDK NIH HHS
  grantid: F31 DK104528
– fundername: NIGMS NIH HHS
  grantid: P20-GM109091
– fundername: NIGMS NIH HHS
  grantid: P20 GM109091
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
2WC
3O-
4.4
53G
5GY
5RE
5VS
8WZ
A6W
AAJMC
AALRI
AAXUO
AAYOK
ABCQX
ABIVO
ABJNI
ABOCM
ABSQV
ACGFO
ACGFS
ACNCT
ADBBV
ADCOW
ADIYS
AENEX
AERNN
AFFNX
AFHIN
AFOSN
AGFXO
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
F9R
FDB
GX1
H13
HZ~
INIJC
KQ8
L7B
LSO
M41
MJL
MVM
O9-
OHT
OK1
P2P
PKN
R.V
R0Z
RHF
RHI
ROL
RPT
TR2
UQL
VH1
W2D
W8F
WH7
WOQ
X7M
YBU
YHG
YQT
ZGI
ZXP
AAYXX
ACVFH
ADCNI
AETEA
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c3588-f3939e5eb30d09fb3b60aae5554f3f8f629db30731150c54ddfdfe2c2253d9433
ISSN 0022-3565
1521-0103
IngestDate Thu Aug 21 18:14:07 EDT 2025
Fri Jul 11 07:57:12 EDT 2025
Sat Mar 08 01:25:23 EST 2025
Thu Apr 24 22:50:00 EDT 2025
Tue Jul 01 05:28:18 EDT 2025
Sat Feb 15 15:51:29 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords PBS
DMSO
L-364,373
KV
ICA-27243
ML-213
BSA
OAB
EFS
CaV
TTX
XE991
ICA-069673
DSM
Language English
License Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3588-f3939e5eb30d09fb3b60aae5554f3f8f629db30731150c54ddfdfe2c2253d9433
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://jpet.aspetjournals.org/content/jpet/354/3/290.full.pdf
PMID 26087697
PQID 1698964069
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4538873
proquest_miscellaneous_1698964069
pubmed_primary_26087697
crossref_primary_10_1124_jpet_115_225268
crossref_citationtrail_10_1124_jpet_115_225268
elsevier_sciencedirect_doi_10_1124_jpet_115_225268
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2015
2015-09-00
2015-Sep
20150901
PublicationDateYYYYMMDD 2015-09-01
PublicationDate_xml – month: 09
  year: 2015
  text: September 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda, MD
PublicationTitle The Journal of pharmacology and experimental therapeutics
PublicationTitleAlternate J Pharmacol Exp Ther
PublicationYear 2015
Publisher Elsevier Inc
The American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: Elsevier Inc
– name: The American Society for Pharmacology and Experimental Therapeutics
References Anderson, Carson, Johnston, Joshi, Gurney, McCloskey (bib4) 2013; 169
Svalø, Bille, Parameswaran Theepakaran, Sheykhzade, Nordling, Bouchelouche (bib34) 2013; 715
Andersson, Wein (bib6) 2004; 56
Gunthorpe, Large, Sankar (bib15) 2012; 53
Amato, Roeloffs, Rigdon, Antonio, Mersch, McNaughton-Smith, Wickenden, Fritch, Suto (bib3) 2011; 2
Ng, Davis, Jepps, Harhun, Yeung, Wan, Reddy, Melville, Nardi, Khong (bib22) 2011; 162
Smith, Hristov, Cheng, Xin, Parajuli, Earley, Malysz, Petkov (bib30) 2013; 304
Andersson, Arner (bib5) 2004; 84
Sheldon J, Davis A, Wesley Norton N, Woods M, Carson N, Wang Q, Mitchell R, Littrell J, and Argentieri T (2002) Evidence for KCNQ gene expression and M-current activity in rat and human urinary bladder smooth muscle (Abstract), in ASPET–Ray Fuller Symposium Series: Diseases of Aging-1: Lower Urinary Tract Disorders–Physiology, Pharmacology and Therapeutic Approaches; 2002 Jul 6–7; San Francisco, CA. American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD.
Svalø, Hansen, Rønn, Sheykhzade, Munro, Rode (bib35) 2012; 110
Svalø, Sheykhzade, Nordling, Matras, Bouchelouche (bib36) 2015; 10
Afeli, Malysz, Petkov (bib2) 2013; 8
Brickel, Gandhi, VanLandingham, Hammond, DeRossett (bib8) 2012; 53
Roeloffs, Wickenden, Crean, Werness, McNaughton-Smith, Stables, McNamara, Ghodadra, Rigdon (bib28) 2008; 326
Soldovieri, Miceli, Taglialatela (bib31) 2011; 26
Xiong, Gao, Wang, Li (bib39) 2008; 29
Brueggemann, Haick, Neuburg, Tate, Randhawa, Cribbs, Byron (bib10) 2014; 306
Mani, O’Dowd, Kumar, Brueggemann, Ross, Byron (bib21) 2013; 61
Chadha, Jepps, Carr, Stott, Zhu, Cole, Greenwood (bib12) 2014; 34
Argentieri T, Sheldon J, and Bowlby M (2002), inventors, American Home Products Corporation, assignee. Methods for modulating bladder function. U.S. patent 6348486. 2002 Feb 19.
Hristov, Chen, Soder, Parajuli, Cheng, Kellett, Petkov (bib17) 2012; 302
Jepps, Chadha, Davis, Harhun, Cockerill, Olesen, Hansen, Greenwood (bib19) 2011; 124
Jepps, Bentzen, Stott, Povstyan, Sivaloganathan, Dalby-Brown, Greenwood (bib18) 2014; 171
Brueggemann, Kakad, Love, Solway, Dowell, Cribbs, Byron (bib11) 2012; 302
Chen, Kellett, Petkov (bib13) 2010; 299
Wrobel, Tapken, Seebohm (bib38) 2012; 3
Jepps, Greenwood, Moffatt, Sanders, Ohya (bib20) 2009; 297
Wickenden, Krajewski, London, Wagoner, Wilson, Clark, Roeloffs, McNaughton-Smith, Rigdon (bib37) 2008; 73
Brueggemann, Haick, Cribbs, Byron (bib9) 2014; 86
Abbott, Goldstein (bib1) 2001; 1
Petkov (bib25) 2014; 307
Greenwood, Ohya (bib14) 2009; 156
Robbins (bib26) 2001; 90
Streng, Christoph, Andersson (bib33) 2004; 172
Hristov, Chen, Afeli, Cheng, Rovner, Petkov (bib16) 2012; 302
Peretz, Pell, Gofman, Haitin, Shamgar, Patrich, Kornilov, Gourgy-Hacohen, Ben-Tal, Attali (bib23) 2010; 107
Rode, Svalø, Sheykhzade, Rønn (bib27) 2010; 638
Stott, Jepps, Greenwood (bib32) 2014; 19
Petkov (bib24) 2012; 9
Rode (10.1124/jpet.115.225268_bib27) 2010; 638
Brueggemann (10.1124/jpet.115.225268_bib9) 2014; 86
Roeloffs (10.1124/jpet.115.225268_bib28) 2008; 326
Chen (10.1124/jpet.115.225268_bib13) 2010; 299
Jepps (10.1124/jpet.115.225268_bib19) 2011; 124
Mani (10.1124/jpet.115.225268_bib21) 2013; 61
Peretz (10.1124/jpet.115.225268_bib23) 2010; 107
Svalø (10.1124/jpet.115.225268_bib35) 2012; 110
Hristov (10.1124/jpet.115.225268_bib17) 2012; 302
Jepps (10.1124/jpet.115.225268_bib20) 2009; 297
Soldovieri (10.1124/jpet.115.225268_bib31) 2011; 26
Amato (10.1124/jpet.115.225268_bib3) 2011; 2
Svalø (10.1124/jpet.115.225268_bib36) 2015; 10
Greenwood (10.1124/jpet.115.225268_bib14) 2009; 156
Wrobel (10.1124/jpet.115.225268_bib38) 2012; 3
Afeli (10.1124/jpet.115.225268_bib2) 2013; 8
Abbott (10.1124/jpet.115.225268_bib1) 2001; 1
Anderson (10.1124/jpet.115.225268_bib4) 2013; 169
Chadha (10.1124/jpet.115.225268_bib12) 2014; 34
Hristov (10.1124/jpet.115.225268_bib16) 2012; 302
Robbins (10.1124/jpet.115.225268_bib26) 2001; 90
10.1124/jpet.115.225268_bib29
Brickel (10.1124/jpet.115.225268_bib8) 2012; 53
Xiong (10.1124/jpet.115.225268_bib39) 2008; 29
Brueggemann (10.1124/jpet.115.225268_bib10) 2014; 306
Wickenden (10.1124/jpet.115.225268_bib37) 2008; 73
10.1124/jpet.115.225268_bib7
Petkov (10.1124/jpet.115.225268_bib25) 2014; 307
Stott (10.1124/jpet.115.225268_bib32) 2014; 19
Ng (10.1124/jpet.115.225268_bib22) 2011; 162
Streng (10.1124/jpet.115.225268_bib33) 2004; 172
Andersson (10.1124/jpet.115.225268_bib6) 2004; 56
Smith (10.1124/jpet.115.225268_bib30) 2013; 304
Andersson (10.1124/jpet.115.225268_bib5) 2004; 84
Brueggemann (10.1124/jpet.115.225268_bib11) 2012; 302
Jepps (10.1124/jpet.115.225268_bib18) 2014; 171
Svalø (10.1124/jpet.115.225268_bib34) 2013; 715
Petkov (10.1124/jpet.115.225268_bib24) 2012; 9
Gunthorpe (10.1124/jpet.115.225268_bib15) 2012; 53
References_xml – volume: 169
  start-page: 1290
  year: 2013
  end-page: 1304
  ident: bib4
  article-title: Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity
  publication-title: Br J Pharmacol
– volume: 306
  start-page: L476
  year: 2014
  end-page: L486
  ident: bib10
  article-title: KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways
  publication-title: Am J Physiol Lung Cell Mol Physiol
– volume: 307
  start-page: R571
  year: 2014
  end-page: R584
  ident: bib25
  article-title: Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology
  publication-title: Am J Physiol Regul Integr Comp Physiol
– volume: 638
  start-page: 121
  year: 2010
  end-page: 127
  ident: bib27
  article-title: Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder
  publication-title: Eur J Pharmacol
– volume: 86
  start-page: 330
  year: 2014
  end-page: 341
  ident: bib9
  article-title: Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673
  publication-title: Mol Pharmacol
– volume: 53
  start-page: 412
  year: 2012
  end-page: 424
  ident: bib15
  article-title: The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy
  publication-title: Epilepsia
– volume: 110
  start-page: 145
  year: 2012
  end-page: 153
  ident: bib35
  article-title: Kv 7 positive modulators reduce detrusor overactivity and increase bladder capacity in rats
  publication-title: Basic Clin Pharmacol Toxicol
– volume: 172
  start-page: 2054
  year: 2004
  end-page: 2058
  ident: bib33
  article-title: Urodynamic effects of the K
  publication-title: J Urol
– volume: 302
  start-page: C360
  year: 2012
  end-page: C372
  ident: bib17
  article-title: K
  publication-title: Am J Physiol Cell Physiol
– volume: 2
  start-page: 481
  year: 2011
  end-page: 484
  ident: bib3
  article-title: N-pyridyl and pyrimidine benzamides as KCNQ2/Q3 potassium channel openers for the treatment of epilepsy
  publication-title: ACS Med Chem Lett
– volume: 304
  start-page: C467
  year: 2013
  end-page: C477
  ident: bib30
  article-title: Novel role for the transient potential receptor melastatin 4 channel in guinea pig detrusor smooth muscle physiology
  publication-title: Am J Physiol Cell Physiol
– volume: 61
  start-page: 51
  year: 2013
  end-page: 62
  ident: bib21
  article-title: Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm
  publication-title: J Cardiovasc Pharmacol
– volume: 1
  start-page: 95
  year: 2001
  end-page: 107
  ident: bib1
  article-title: Potassium channel subunits encoded by the KCNE gene family: physiology and pathophysiology of the MinK-related peptides (MiRPs)
  publication-title: Mol Interv
– volume: 9
  start-page: 30
  year: 2012
  end-page: 40
  ident: bib24
  article-title: Role of potassium ion channels in detrusor smooth muscle function and dysfunction
  publication-title: Nat Rev Urol
– volume: 84
  start-page: 935
  year: 2004
  end-page: 986
  ident: bib5
  article-title: Urinary bladder contraction and relaxation: physiology and pathophysiology
  publication-title: Physiol Rev
– volume: 26
  start-page: 365
  year: 2011
  end-page: 376
  ident: bib31
  article-title: Driving with no brakes: molecular pathophysiology of Kv7 potassium channels
  publication-title: Physiology (Bethesda)
– volume: 56
  start-page: 581
  year: 2004
  end-page: 631
  ident: bib6
  article-title: Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence
  publication-title: Pharmacol Rev
– volume: 326
  start-page: 818
  year: 2008
  end-page: 828
  ident: bib28
  article-title: In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models
  publication-title: J Pharmacol Exp Ther
– volume: 302
  start-page: C1599
  year: 2012
  end-page: C1608
  ident: bib16
  article-title: Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle
  publication-title: Am J Physiol Cell Physiol
– volume: 162
  start-page: 42
  year: 2011
  end-page: 53
  ident: bib22
  article-title: Expression and function of the K
  publication-title: Br J Pharmacol
– volume: 29
  start-page: 99
  year: 2008
  end-page: 107
  ident: bib39
  article-title: Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds
  publication-title: Trends Pharmacol Sci
– reference: Argentieri T, Sheldon J, and Bowlby M (2002), inventors, American Home Products Corporation, assignee. Methods for modulating bladder function. U.S. patent 6348486. 2002 Feb 19.
– volume: 156
  start-page: 1196
  year: 2009
  end-page: 1203
  ident: bib14
  article-title: New tricks for old dogs: KCNQ expression and role in smooth muscle
  publication-title: Br J Pharmacol
– reference: Sheldon J, Davis A, Wesley Norton N, Woods M, Carson N, Wang Q, Mitchell R, Littrell J, and Argentieri T (2002) Evidence for KCNQ gene expression and M-current activity in rat and human urinary bladder smooth muscle (Abstract), in ASPET–Ray Fuller Symposium Series: Diseases of Aging-1: Lower Urinary Tract Disorders–Physiology, Pharmacology and Therapeutic Approaches; 2002 Jul 6–7; San Francisco, CA. American Society for Pharmacology and Experimental Therapeutics, Bethesda, MD.
– volume: 53
  start-page: 606
  year: 2012
  end-page: 612
  ident: bib8
  article-title: The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels
  publication-title: Epilepsia
– volume: 10
  start-page: e0117350
  year: 2015
  ident: bib36
  article-title: Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction
  publication-title: PLoS One
– volume: 90
  start-page: 1
  year: 2001
  end-page: 19
  ident: bib26
  article-title: KCNQ potassium channels: physiology, pathophysiology, and pharmacology
  publication-title: Pharmacol Ther
– volume: 171
  start-page: 4413
  year: 2014
  end-page: 4424
  ident: bib18
  article-title: Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370
  publication-title: Br J Pharmacol
– volume: 73
  start-page: 977
  year: 2008
  end-page: 986
  ident: bib37
  article-title: N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator
  publication-title: Mol Pharmacol
– volume: 107
  start-page: 15637
  year: 2010
  end-page: 15642
  ident: bib23
  article-title: Targeting the voltage sensor of Kv7.2 voltage-gated K
  publication-title: Proc Natl Acad Sci USA
– volume: 302
  start-page: L120
  year: 2012
  end-page: L132
  ident: bib11
  article-title: Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy
  publication-title: Am J Physiol Lung Cell Mol Physiol
– volume: 8
  start-page: e75875
  year: 2013
  ident: bib2
  article-title: Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle
  publication-title: PLoS One
– volume: 297
  start-page: G107
  year: 2009
  end-page: G115
  ident: bib20
  article-title: Molecular and functional characterization of Kv7 K
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 715
  start-page: 312
  year: 2013
  end-page: 320
  ident: bib34
  article-title: Bladder contractility is modulated by Kv7 channels in pig detrusor
  publication-title: Eur J Pharmacol
– volume: 19
  start-page: 413
  year: 2014
  end-page: 424
  ident: bib32
  article-title: K(
  publication-title: Drug Discov Today
– volume: 34
  start-page: 887
  year: 2014
  end-page: 893
  ident: bib12
  article-title: Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 299
  start-page: R177
  year: 2010
  end-page: R184
  ident: bib13
  article-title: Voltage-gated K(+) channels sensitive to stromatoxin-1 regulate myogenic and neurogenic contractions of rat urinary bladder smooth muscle
  publication-title: Am J Physiol Regul Integr Comp Physiol
– volume: 124
  start-page: 602
  year: 2011
  end-page: 611
  ident: bib19
  article-title: Downregulation of Kv7.4 channel activity in primary and secondary hypertension
  publication-title: Circulation
– volume: 3
  start-page: 142
  year: 2012
  ident: bib38
  article-title: The KCNE tango - how KCNE1 interacts with Kv7.1
  publication-title: Front Pharmacol
– volume: 84
  start-page: 935
  year: 2004
  ident: 10.1124/jpet.115.225268_bib5
  article-title: Urinary bladder contraction and relaxation: physiology and pathophysiology
  publication-title: Physiol Rev
  doi: 10.1152/physrev.00038.2003
– volume: 171
  start-page: 4413
  year: 2014
  ident: 10.1124/jpet.115.225268_bib18
  article-title: Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.12805
– volume: 53
  start-page: 606
  year: 2012
  ident: 10.1124/jpet.115.225268_bib8
  article-title: The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2012.03441.x
– ident: 10.1124/jpet.115.225268_bib29
– volume: 26
  start-page: 365
  year: 2011
  ident: 10.1124/jpet.115.225268_bib31
  article-title: Driving with no brakes: molecular pathophysiology of Kv7 potassium channels
  publication-title: Physiology (Bethesda)
– volume: 29
  start-page: 99
  year: 2008
  ident: 10.1124/jpet.115.225268_bib39
  article-title: Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2007.11.010
– volume: 2
  start-page: 481
  year: 2011
  ident: 10.1124/jpet.115.225268_bib3
  article-title: N-pyridyl and pyrimidine benzamides as KCNQ2/Q3 potassium channel openers for the treatment of epilepsy
  publication-title: ACS Med Chem Lett
  doi: 10.1021/ml200053x
– volume: 86
  start-page: 330
  year: 2014
  ident: 10.1124/jpet.115.225268_bib9
  article-title: Differential activation of vascular smooth muscle Kv7.4, Kv7.5, and Kv7.4/7.5 channels by ML213 and ICA-069673
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.114.093799
– volume: 61
  start-page: 51
  year: 2013
  ident: 10.1124/jpet.115.225268_bib21
  article-title: Vascular KCNQ (Kv7) potassium channels as common signaling intermediates and therapeutic targets in cerebral vasospasm
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/FJC.0b013e3182771708
– volume: 307
  start-page: R571
  year: 2014
  ident: 10.1124/jpet.115.225268_bib25
  article-title: Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00142.2014
– volume: 56
  start-page: 581
  year: 2004
  ident: 10.1124/jpet.115.225268_bib6
  article-title: Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence
  publication-title: Pharmacol Rev
  doi: 10.1124/pr.56.4.4
– volume: 302
  start-page: L120
  year: 2012
  ident: 10.1124/jpet.115.225268_bib11
  article-title: Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00194.2011
– volume: 19
  start-page: 413
  year: 2014
  ident: 10.1124/jpet.115.225268_bib32
  article-title: K(V)7 potassium channels: a new therapeutic target in smooth muscle disorders
  publication-title: Drug Discov Today
  doi: 10.1016/j.drudis.2013.12.003
– volume: 73
  start-page: 977
  year: 2008
  ident: 10.1124/jpet.115.225268_bib37
  article-title: N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator
  publication-title: Mol Pharmacol
  doi: 10.1124/mol.107.043216
– volume: 162
  start-page: 42
  year: 2011
  ident: 10.1124/jpet.115.225268_bib22
  article-title: Expression and function of the K+ channel KCNQ genes in human arteries
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.2010.01027.x
– volume: 326
  start-page: 818
  year: 2008
  ident: 10.1124/jpet.115.225268_bib28
  article-title: In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.108.137794
– volume: 10
  start-page: e0117350
  year: 2015
  ident: 10.1124/jpet.115.225268_bib36
  article-title: Functional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0117350
– volume: 297
  start-page: G107
  year: 2009
  ident: 10.1124/jpet.115.225268_bib20
  article-title: Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles
  publication-title: Am J Physiol Gastrointest Liver Physiol
  doi: 10.1152/ajpgi.00057.2009
– ident: 10.1124/jpet.115.225268_bib7
– volume: 124
  start-page: 602
  year: 2011
  ident: 10.1124/jpet.115.225268_bib19
  article-title: Downregulation of Kv7.4 channel activity in primary and secondary hypertension
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.032136
– volume: 1
  start-page: 95
  year: 2001
  ident: 10.1124/jpet.115.225268_bib1
  article-title: Potassium channel subunits encoded by the KCNE gene family: physiology and pathophysiology of the MinK-related peptides (MiRPs)
  publication-title: Mol Interv
– volume: 156
  start-page: 1196
  year: 2009
  ident: 10.1124/jpet.115.225268_bib14
  article-title: New tricks for old dogs: KCNQ expression and role in smooth muscle
  publication-title: Br J Pharmacol
  doi: 10.1111/j.1476-5381.2009.00131.x
– volume: 8
  start-page: e75875
  year: 2013
  ident: 10.1124/jpet.115.225268_bib2
  article-title: Molecular expression and pharmacological evidence for a functional role of kv7 channel subtypes in Guinea pig urinary bladder smooth muscle
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0075875
– volume: 3
  start-page: 142
  year: 2012
  ident: 10.1124/jpet.115.225268_bib38
  article-title: The KCNE tango - how KCNE1 interacts with Kv7.1
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2012.00142
– volume: 302
  start-page: C1599
  year: 2012
  ident: 10.1124/jpet.115.225268_bib16
  article-title: Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00447.2011
– volume: 172
  start-page: 2054
  year: 2004
  ident: 10.1124/jpet.115.225268_bib33
  article-title: Urodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving, conscious rats
  publication-title: J Urol
  doi: 10.1097/01.ju.0000138155.33749.f4
– volume: 715
  start-page: 312
  year: 2013
  ident: 10.1124/jpet.115.225268_bib34
  article-title: Bladder contractility is modulated by Kv7 channels in pig detrusor
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2013.05.005
– volume: 9
  start-page: 30
  year: 2012
  ident: 10.1124/jpet.115.225268_bib24
  article-title: Role of potassium ion channels in detrusor smooth muscle function and dysfunction
  publication-title: Nat Rev Urol
  doi: 10.1038/nrurol.2011.194
– volume: 169
  start-page: 1290
  year: 2013
  ident: 10.1124/jpet.115.225268_bib4
  article-title: Functional expression of KCNQ (Kv7) channels in guinea pig bladder smooth muscle and their contribution to spontaneous activity
  publication-title: Br J Pharmacol
  doi: 10.1111/bph.12210
– volume: 107
  start-page: 15637
  year: 2010
  ident: 10.1124/jpet.115.225268_bib23
  article-title: Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0911294107
– volume: 110
  start-page: 145
  year: 2012
  ident: 10.1124/jpet.115.225268_bib35
  article-title: Kv 7 positive modulators reduce detrusor overactivity and increase bladder capacity in rats
  publication-title: Basic Clin Pharmacol Toxicol
  doi: 10.1111/j.1742-7843.2011.00765.x
– volume: 53
  start-page: 412
  year: 2012
  ident: 10.1124/jpet.115.225268_bib15
  article-title: The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2011.03365.x
– volume: 638
  start-page: 121
  year: 2010
  ident: 10.1124/jpet.115.225268_bib27
  article-title: Functional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladder
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2010.03.050
– volume: 90
  start-page: 1
  year: 2001
  ident: 10.1124/jpet.115.225268_bib26
  article-title: KCNQ potassium channels: physiology, pathophysiology, and pharmacology
  publication-title: Pharmacol Ther
  doi: 10.1016/S0163-7258(01)00116-4
– volume: 299
  start-page: R177
  year: 2010
  ident: 10.1124/jpet.115.225268_bib13
  article-title: Voltage-gated K(+) channels sensitive to stromatoxin-1 regulate myogenic and neurogenic contractions of rat urinary bladder smooth muscle
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00036.2010
– volume: 306
  start-page: L476
  year: 2014
  ident: 10.1124/jpet.115.225268_bib10
  article-title: KCNQ (Kv7) potassium channel activators as bronchodilators: combination with a β2-adrenergic agonist enhances relaxation of rat airways
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00253.2013
– volume: 34
  start-page: 887
  year: 2014
  ident: 10.1124/jpet.115.225268_bib12
  article-title: Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.114.303405
– volume: 304
  start-page: C467
  year: 2013
  ident: 10.1124/jpet.115.225268_bib30
  article-title: Novel role for the transient potential receptor melastatin 4 channel in guinea pig detrusor smooth muscle physiology
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00169.2012
– volume: 302
  start-page: C360
  year: 2012
  ident: 10.1124/jpet.115.225268_bib17
  article-title: KV2.1 and electrically silent KV channel subunits control excitability and contractility of guinea pig detrusor smooth muscle
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00303.2010
SSID ssj0014463
Score 2.250594
Snippet The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1–KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate...
The physiologic roles of voltage-gated KV7 channel subtypes (KV7.1-KV7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to elucidate...
The physiologic roles of voltage-gated K V 7 channel subtypes (K V 7.1–K V 7.5) in detrusor smooth muscle (DSM) are poorly understood. Here, we sought to...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 290
SubjectTerms Action Potentials - drug effects
Action Potentials - physiology
Animals
Benzamides - pharmacology
Calcium - metabolism
Calcium Channels, L-Type - metabolism
Cell Membrane - drug effects
Cell Membrane - metabolism
Gastrointestinal, Hepatic, Pulmonary, and Renal
Guinea Pigs
KCNQ2 Potassium Channel - metabolism
KCNQ3 Potassium Channel - metabolism
Male
Muscle Contraction - drug effects
Muscle Contraction - physiology
Muscle, Smooth - drug effects
Muscle, Smooth - metabolism
Myocytes, Smooth Muscle - drug effects
Myocytes, Smooth Muscle - metabolism
Potassium - metabolism
Title The Novel KV7.2/KV7.3 Channel Opener ICA-069673 Reveals Subtype-Specific Functional Roles in Guinea Pig Detrusor Smooth Muscle Excitability and Contractility
URI https://dx.doi.org/10.1124/jpet.115.225268
https://www.ncbi.nlm.nih.gov/pubmed/26087697
https://www.proquest.com/docview/1698964069
https://pubmed.ncbi.nlm.nih.gov/PMC4538873
Volume 354
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db5swELfa7mUv076XfcmTpmoShQLmIzxGUbpuVapsS6u-ITCmi9aSKE2qrf_L_tfd2Q44dJG2vhBkcDC6-92dje93hLwvXY65PIHtl8y1weDFdlJk3I7AF_KQe6XnYe7w8Dg6PAk-n4VnW9vU2LW0XOQOv_lrXsldpAptIFfMkv0PydZ_Cg1wDvKFI0gYjv8s4-Pptbiwjk5jBzlO8ZfJlIEKWnG3iJhbn_o9242SKGb4KUAgYTLYC1x8tWX5-XLCrQPwb3pZ8CtyPOE6yMclhKCZNZqcg1nC5Izp3Pp2OQXZWsPlFYzFGvzkk4Vi-lY8Tkh2JfOusMUMfJsUNBn8zhrGbNVxrdKAkRRWh_yjObxopZb8e9m82T0wRFaVm_a24pFY_Jhe16v-E-vUMRc4vLDewaVUctxk2FRrW1lH7ZEOzJGO2yM1kxdUeQpHaJvv44qKy0ynwBS1tdZ-Zpp4Vd5URwtMjfS2I_IDdEQw84Hz0AGr6avyQYZazi6lXsKMElyS2qXc4v4eDfsBeKRuzLbJPR8mQmjJj74038lgMs9qPnx4LU1eBU_fbz0bWa_1gzaFYLenWO2dwkboNX5IHmi1oT0FgEdkS1SPya4WzK89agphj-5SU2RPyG-4TCVKqETJvsQI1RihCiO0wQjVGKFtjNAGI1RihE4qqjBCASN0hRGqMEIVRqiJEQoKRNcw8pScHAzG_UNbFyWxOQvB_pQsYYkIRc7cwk3KnOWRm2UihLC8ZGW3jPykyNFx4lSLh0FRlEUpfA5SYEUSMPaM7FTTSrwgVORBxl2vLLLEDzgv8q6sBB5lPPRjPyg6xFnJKeWasR8Lx1ykcubuBynKGM7CVMm4Qz7UHWaKrGbzrf5K8KmOtVUMnYIGb-70bqUiKXgh_LSYVWK6vEo9rEMbYRZ9hzxXKlOPYKV2HRKvKVN9AzLcr1-pJt8l071W_pd37vmK3G9MymuyA3og3sAsYpG_lUD6A_h0Itw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Novel+KV7.2%2FKV7.3+Channel+Opener+ICA-069673+Reveals+Subtype-Specific+Functional+Roles+in+Guinea+Pig+Detrusor+Smooth+Muscle+Excitability+and+Contractility&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Provence%2C+Aaron&rft.au=Malysz%2C+John&rft.au=Petkov%2C+Georgi+V.&rft.date=2015-09-01&rft.pub=The+American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=354&rft.issue=3&rft.spage=290&rft.epage=301&rft_id=info:doi/10.1124%2Fjpet.115.225268&rft_id=info%3Apmid%2F26087697&rft.externalDocID=PMC4538873
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon